-+ 0.00%
-+ 0.00%
-+ 0.00%

Gain Therapeutics Plans To Initiate Phase 2 Rexaceract Trial In Q1 Next Year

Benzinga·10/01/2026 13:20:48
Listen to the news

https://www.sec.gov/ix?doc=/Archives/edgar/data/1819411/000110465926112624/tm2626750d1_8k.htm